OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 39 filers reported holding OCUPHIRE PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,505 | +30.0% | 93,285 | +68.4% | 0.00% | – |
| Q2 2023 | $240,432 | +22.8% | 55,399 | +6.1% | 0.00% | – |
| Q1 2023 | $195,754 | -22.7% | 52,201 | -27.2% | 0.00% | – |
| Q4 2022 | $253,108 | +87.5% | 71,702 | +7.5% | 0.00% | – |
| Q3 2022 | $135,000 | -0.7% | 66,717 | -6.3% | 0.00% | – |
| Q2 2022 | $136,000 | +21.4% | 71,169 | +107.7% | 0.00% | – |
| Q1 2022 | $112,000 | -15.8% | 34,266 | -3.8% | 0.00% | – |
| Q4 2021 | $133,000 | -24.0% | 35,607 | +5.0% | 0.00% | – |
| Q3 2021 | $175,000 | -3.3% | 33,913 | -1.5% | 0.00% | – |
| Q2 2021 | $181,000 | +1292.3% | 34,427 | +1459.9% | 0.00% | – |
| Q1 2021 | $13,000 | -13.3% | 2,207 | 0.0% | 0.00% | – |
| Q4 2020 | $15,000 | – | 2,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
| Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
| NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
| Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
| MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
| Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
| MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
| Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |